Fighting Europe ’s second wave of COVID-19, and making democracy work for poor people
First up this week, Contributing Correspondent Kai Kupferschmidt talks with host Sarah Crespi about rising numbers of coronavirus cases in Europe. Will what we ’ve learned this summer about how the virus is transmitted and treated help prevent a second peak? Read all of our coronavirus news coverage. And as part of a special issue on democracy, Rohini Pande, a professor in the department of economics at Yale University, joins Sarah to discuss her revie w that asks the question: Can democracy work for poor people? Read more from the special issue on democracy. This week’s episode was produced with help from P...
Source: Science Magazine Podcast - August 31, 2020 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts

TWiV 655: Minority health with Robert Fullilove
Sociomedical scientist Robert Fullilove joins TWiV to discuss disparities in minority health; FDA announces an EUA on Yale's SalivaDirect, protection of the upper and respiratory tract of mice after intranasal inoculation with an adenovirus-vectored SARS-CoV-2 spike gene, and listener questions. Hosts: Vincent Racaniello, Rich Condit, Kathy Spindler, and Brianne Barker Guest: Robert Fullilove Click arrow to play Download TWiV 652 (69 MB .mp3, 114 min)Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Health of racial and ethnic ...
Source: This Week in Virology - MP3 Edition - August 20, 2020 Category: Virology Authors: Vincent Racaniello Source Type: podcasts

Counting the ways Donald Trump failed in the pandemic
The Trump administration was left a playbook for pandemics when they entered the Whitehouse, but even before covid-19 was a threat systematically dismantled the public health protections put in place to follow that playbook. In this podcast, Nicole Lurie, Gavin Yamey and Gregg Gonsalves talk about how the US response to public health was mismanaged, how it has become politicized, and what that playbook suggested should have been done. They also talk about rebuilding public health in the US after this is all over. Our guests; Nicole Lurie, former Assistant Secretary for Preparedness and Response under the Obama administr...
Source: The BMJ Podcast - June 5, 2020 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts

Talk evidence covid-19 update - natural history of covid, include patients in guidelines
For the next few months Talk Evidence is going to focus on the new corona virus pandemic. There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing. We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues. This week: (1.20) Carl gives us an update on the England and Wales admission data. (3.00) Helen talks about ways in which spread and severity of infectio n amongst household contacts. (8.20) We talk natural history of covid-19, and Harlan Krum...
Source: The BMJ Podcast - May 9, 2020 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts

Coronavirus Disease 2019 (COVID-19) Update: Epidemics in History
Infectious epidemics have always driven change and triggered discrimination in human societies. Frank Snowden, DPhil, Professor Emeritus of History and History of Medicine at Yale University and author of Epidemics and Society: From the Black Death to the Present (Yale University Press, 2019), puts the COVID-19 pandemic in historical context. (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - April 6, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts

Coronavirus (COVID-19) Update: The Near Future
How does the current pandemic compare to historical infectious outbreaks and what can we expect in summer and fall of 2020? Nicholas Christakis, MD, PhD, MPH, director of the Human Nature Lab, Co-director of the Institute of Network Science, and Sterling Professor of Social and Natural Science at Yale University, discusses the epidemiology of COVID-19. (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - April 1, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts

Pollution from pot plants, and how our bodies perceive processed foods
The “dank” smelling terpenes emitted by growing marijuana can combine with chemicals in car emissions to form ozone, a health-damaging compound. This is especially problematic in Denver, where ozone levels are dangerously high and pot farms have sprung up along two highways in the city. Host Sarah C respi talks with reporter Jason Plautz about researchers’ efforts to measure terpene emissions from pot plants and how federal restrictions have hampered them. Next, host Meagan Cantwell talks with Dana Small, a professor of psychiatry and psychology at Yale University, about how processed foods are perc...
Source: Science Magazine Podcast - January 24, 2019 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts

Pollution from pot plants, and how our bodies perceive processed foods
The “dank” smelling terpenes emitted by growing marijuana can combine with chemicals in car emissions to form ozone, a health-damaging compound. This is especially problematic in Denver, where ozone levels are dangerously high and pot farms have sprung up along two highways in the city. Host Sarah C respi talks with reporter Jason Plautz about researchers’ efforts to measure terpene emissions from pot plants and how federal restrictions have hampered them. Next, host Meagan Cantwell talks with Dana Small, a professor of psychiatry and psychology at Yale University, about how processed foods are perc...
Source: Science Magazine Podcast - January 24, 2019 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts

Transfusion Independance With Hypomethylating agents
Amer Zeidan, MBBS Assistant Professor of Medicine (Hematology) at Yale University Discusses Transfusion Independance With Hypomethylating agents At The 60th ASH Annual Meeting on Dec 1, 2018. Author: ASHReport Added: 12/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - December 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Is Patient Survival Based On Physician Experience
Amer Zeidan, MBBS Assistant Professor of Medicine (Hematology) at Yale University Discusses Is Patient Survival Based On Physician Experience At The 60th ASH Annual Meeting on Dec 1, 2018. Author: ASHReport Added: 12/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - December 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Exploiting oncometabolite-induced DNA repair defects
Ranjit S. Bindra, M.D., Ph.D. Associate Professor Departments of Therapeutic Radiology and Experimental Pathology Yale Cancer Center discusses Exploiting oncometabolite-induced DNA repair defects Fro... Author: kidneycancer Added: 11/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Pathobiology and clinical management of T-cell lymphoma
From the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2018 meeting held in Nice, France, Francine Foss, MD, of Yale University School of Medicine, New Haven, CT, discusses the pathology and... Author: VJHemOnc Added: 10/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 1, 2018 Category: Cancer & Oncology Source Type: podcasts

S1500's Completion May Alter Standard of Care for PRCC Compares 3 pool MET inhibitors to Sutent as a comparator arm
Brian M. Shuch, MD Yale School of Medicine, discusses how S1500's Completion May Alter Standard of Care for PRCC Compares 3 pool MET inhibitors to Sutent as a comparator arm at Kidney Cancer Associat... Author: kidneycancer Added: 04/03/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 4, 2018 Category: Cancer & Oncology Source Type: podcasts

SWOG S1500 - Randomized Phase II Trial Efficacy assessment of multiple MET kinase inhibitors in metastatic PRCC
Brian M. Shuch, MD Yale School of Medicine, discusses the SWOG S1500 - Randomized Phase II Trial Efficacy assessment of multiple MET kinase inhibitors in metastatic PRCC at Kidney Cancer Association 2... Author: kidneycancer Added: 04/03/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 3, 2018 Category: Cancer & Oncology Source Type: podcasts

Difference Between Type 1 & 2 PRCC Although look similar on light microscopy, they have different biology
Brian M. Shuch, MD Yale School of Medicine, discusses the Difference Between Type 1 & 2 PRCC Although look similar on light microscopy, they have different biology at Kidney Cancer Association 2017 i... Author: kidneycancer Added: 04/03/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 3, 2018 Category: Cancer & Oncology Source Type: podcasts

EGFR Inhibitor Resistant Patients EGFR Antibodies May Play a Role
Roy S. Herbst, MD, PhD of Yale Cancer Center discusses EGFR inhibitor resistant patients and how EGFR antibodies may play a role. From the 22nd Annual Perspectives in Thoracic Oncology in New York htt... Author: thoraciconcology Added: 01/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 4, 2018 Category: Cancer & Oncology Source Type: podcasts

EGFR Small Molecules v Antibodies In Combination Antibodies better than Small Molecules
Roy S. Herbst, MD, PhD of Yale Cancer Center discusses EGFR small molecules v antibodies in combination antibodies better than small molecules. From the 22nd Annual Perspectives in Thoracic Oncology i... Author: thoraciconcology Added: 01/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 4, 2018 Category: Cancer & Oncology Source Type: podcasts

FLAURA Data & Osimertinib High PFS as Front-Line Agent
Roy S. Herbst, MD, PhD of Yale Cancer Center discusses how the FLAURA data & Osimertinib result in high PFS as front-line agent. From the 22nd Annual Perspectives in Thoracic Oncology in New York http... Author: thoraciconcology Added: 01/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Lung Cancer EGFR Antibodies Where is the research going?
Roy S. Herbst, MD, PhD of Yale Cancer Center discusses lung cancer EGFR antibodies and where the research is going. From the 22nd Annual Perspectives in Thoracic Oncology in New York http://imedex.com...... Author: thoraciconcology Added: 01/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Resistance to Osimertinib to create a Flurry of Activity To Find Out Why in 2018
Roy S. Herbst, MD, PhD of Yale Cancer Center discusses resistance to osimertinib to create a flurry of activity to find out why in 2018. From the 22nd Annual Perspectives in Thoracic Oncology in New Y... Author: thoraciconcology Added: 01/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Screening for EGFR Mutation, All Lung Cancer Should Be Screened
Roy S. Herbst, MD, PhD of Yale Cancer Center discusses screening for EGFR mutation and how all lung cancers should be screened. From the 22nd Annual Perspectives in Thoracic Oncology in New York http:... Author: thoraciconcology Added: 01/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Squamous Cell Carcinoma 4+ EGFR Carboplatin Cetuximab Safely or Bevacizumab
Roy S. Herbst, MD, PhD of Yale Cancer Center discusses squamous cell carcinoma 4+ EGFR and giving carboplatin cetuximab safely or bevacizumab. From the 22nd Annual Perspectives in Thoracic Oncology i... Author: thoraciconcology Added: 01/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Targeting chemokines in lymphoma
Francine Foss, MD, from the Yale University School of Medicine, New Haven, CT, discusses targeting chemokines at the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2017 meeting, held in Vancou... Author: VJHemOnc Added: 11/16/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 16, 2017 Category: Cancer & Oncology Source Type: podcasts

Genomic Heterogeneity and the Small Renal Mass
Brian Shuch, MD Assistant Professor of Urology and Radiology Yale School of Medicine Genomic Heterogeneity and the Small Renal Mass discusses Genomic Heterogeneity and the Small Renal Mass at the 201... Author: kidneycancer Added: 11/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2017 Category: Cancer & Oncology Source Type: podcasts

A Biomarker Analysis of MET Alterations and Papillary Subtype in S1500
Brian Shuch, MD of the Yale School of Medicine discusses the Biomarker Analysis of MET Alterations and Papillary Subtype in S1500 at the 2017 Kidney Cancer Association symposium in Miami, FL. Author: kidneycancer Added: 11/07/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 8, 2017 Category: Cancer & Oncology Source Type: podcasts

EndNote Essential Training #7: Managing Full-Text PDFs in EndNote
Over the years, EndNote has grown into not only a mature citation management program, but also a full-text PDF management program. This video demonstrates how to automatically download full-text PDFs for references in your EndNote library, how to import existing PDFs into EndNote and automatically find references for the imported PDFs, how to add your institution's OpenURL path to improve the accuracy in finding full text, and how to use other convenience features for PDF handling in EndNote.View Tutorial Full Size (9 min 10 sec)Download tutorial (MP4 file, 71.40MB) (Source: Tutorials from the Yale Medical Library)
Source: Tutorials from the Yale Medical Library - July 6, 2017 Category: Databases & Libraries Authors: Cushing / Whitney Medical Library Tags: EndNote Source Type: podcasts

What tests should a urothelial carcinoma patient get as part of their work up?
Daniel Petrylak, MD of Yale School of Medicine discusses which tests patients with urothelial carcinoma should receive as part of their cancer care at the 2017 ASCO Annual Meeting in Chicago, IL. Author: obr Added: 06/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2017 Category: Cancer & Oncology Source Type: podcasts

If a urothelial carcinoma patient is progressing on checkpoint inhibitors, whats next for the patient?
Daniel Petrylak, MD of Yale School of Medicine discusses what's next for patient with bladder cancer after checkpoint inhibition therapy at the 2017 ASCO Annual Meeting in Chicago, IL. Author: obr Added: 06/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2017 Category: Cancer & Oncology Source Type: podcasts

Checkpoint inhibition therapy in urothelial carcinoma cancer
Daniel Petrylak, MD of Yale School of Medicine discusses the role of checkpoint inhibition therapy in urothelial carcinoma cancer at the 2017 ASCO Annual Meeting. Author: obr Added: 06/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2017 Category: Cancer & Oncology Source Type: podcasts

Should prostate cancer guidelines be updated based on the LATITUDE study?
Daniel Petrylak, MD of Yale School of Medicine discusses whether or not prostate cancer guidelines should be updated based on the new results of the LATITUDE study. This was recorded at the 2017 ASCO ... Author: obr Added: 06/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2017 Category: Cancer & Oncology Source Type: podcasts

Impact of immunotherapies in the treatment of gastric & amp; GE junction cancers
Howard Hochster, MD of Yale Cancer Center discusses the impact of immunotherapy for the treatment of gastric and GE junction cancers at the 2017 ASCO Annual Meeting in Chicago, IL. Author: obr Added: 06/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2017 Category: Cancer & Oncology Source Type: podcasts

Should stage lll colon cancer patients be treated with 3 months or 6 months of FOLFOX therapy?
Howard Hochster, MD of Yale Cancer Center discusses whether or not stage III colon cancer patients should be treated with either 3 months or 6 months of FOLFOX therapy. This was recorded at the 2017 A... Author: obr Added: 06/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2017 Category: Cancer & Oncology Source Type: podcasts

New peri-operative regimen FLOT vs. ECX for gastric cancer patients
Howard Hochster, MD of Yale Cancer Center discusses new peri-operative treatment regimens for resectable gastric and GE junction cancers at the 2017 ASCO Annual Meeting in Chicago, IL. Author: obr Added: 06/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2017 Category: Cancer & Oncology Source Type: podcasts

Approaches to treating BRAF-mutated positive CRC patients
Howard Hochster, MD of Yale Cancer Center gives an overview of treatments for BRAF-mutated positive colorectal cancer patients at the 2017 ASCO Annual Meeting in Chicago, IL. Author: obr Added: 06/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2017 Category: Cancer & Oncology Source Type: podcasts

Results of the LUX Head and Neck 2 study
Barbara Ann Burtness, MD of Yale Cancer Center gives an overview of the LUX Head and Neck 2 trial, which was presented at the 2017 ASCO Annual Meeting in Chicago, IL. Author: obr Added: 06/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2017 Category: Cancer & Oncology Source Type: podcasts

The Impact of Molecular Subsets on Adjuvant and Advanced Disease Treatment
Howard S. Hochster, MD of Yale School of Medicine gives an overview of his presentation, The Impact of Molecular Subsets on Adjuvant and Advanced Disease Treatment, which was discussed at the 2017 Gre... Author: GiDebates2017 Added: 06/01/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2017 Category: Cancer & Oncology Source Type: podcasts

Importance of Early Molecular Testing in Colon Cancer
Howard S. Hochster, MD of Yale School of Medicine discusses the importance of recommending molecular testing early on to patients with colon cancer. He further explains the significance of HER2 testin... Author: GiDebates2017 Added: 06/01/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2017 Category: Cancer & Oncology Source Type: podcasts

Impact of Molecular Testing on Upcoming Clinical Trials
Howard S. Hochster, MD of Yale School of Medicine discusses the impact of molecular testing and screening on potential clinical trials at the 2017 Great Debates and Updates in GI Malignancies in New Y... Author: GiDebates2017 Added: 06/01/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2017 Category: Cancer & Oncology Source Type: podcasts

EndNote Essential Training #6: Additional Styles and Customizing Styles
This video demonstrates how to find additional or updated styles on endnote.com and add them to your EndNote program, and how to modify an existing style to suit your needs.View Tutorial Full Size (8 min 02 sec)Download tutorial (MP4 file, 60.10MB) (Source: Tutorials from the Yale Medical Library)
Source: Tutorials from the Yale Medical Library - May 4, 2017 Category: Databases & Libraries Authors: Cushing / Whitney Medical Library Tags: EndNote Source Type: podcasts

Drug promotion, prescription, and value
Pharma companies say that money spent on promotion is essential to educate doctors about the best drugs - but when a medical student asked Joseph Ross, associate professor of medicine and public health at Yale, if those companies are promoting the right drugs for that message to be true, the answer wasn't available. Ross and Tyler Greenaway, his... (Source: The BMJ Podcast)
Source: The BMJ Podcast - May 4, 2017 Category: Journals (General) Authors: BMJ talk medicine Source Type: podcasts

EndNote Essential Training #5: Writing Papers with Cite While You Write
This video demonstrates how to use the "Cite While You Write" plugin for Microsoft Word to insert citations to and generate bibliographies in a Word document, how to easily switching to different output styles, and how to generate bibliographies independent of a paper.View Tutorial Full Size (6 min 32 sec)Download tutorial (MP4 file, 62.90MB) (Source: Tutorials from the Yale Medical Library)
Source: Tutorials from the Yale Medical Library - April 18, 2017 Category: Databases & Libraries Authors: Cushing / Whitney Medical Library Tags: EndNote Source Type: podcasts

EndNote X8 Essential Training #4: Manually Creating References
When a reference you want is not importable from any database, it is necessary to create it by hand in EndNote. This video demonstrates the process, and things to pay attention to when doing so. Finally, this video demonstrates how to create a reference for a web page, the most common manually created references in EndNote.View Tutorial Full Size (3 min 49 sec)Download tutorial (MP4 file, 14.90MB) (Source: Tutorials from the Yale Medical Library)
Source: Tutorials from the Yale Medical Library - April 11, 2017 Category: Databases & Libraries Authors: Cushing / Whitney Medical Library Tags: EndNote Source Type: podcasts

EndNote Essential Training #4: Manually Creating References
When a reference you want is not importable from any database, it is necessary to create it by hand in EndNote. This video demonstrates the process, and things to pay attention to when doing so. Finally, this video demonstrates how to create a reference for a web page, the most common manually created references in EndNote.View Tutorial Full Size (3 min 49 sec)Download tutorial (MP4 file, 14.90MB) (Source: Tutorials from the Yale Medical Library)
Source: Tutorials from the Yale Medical Library - April 11, 2017 Category: Databases & Libraries Authors: Cushing / Whitney Medical Library Tags: EndNote Source Type: podcasts

ASCO GI 2017: Immunotherapy in Existing Treatment for GI Cancer Patients
Howard S. Hochster, MD of Yale Cancer Center discusses how healthcare professionals will be integrating immunotherapy into existing treatment regimens for GI cancer patients at the 2017 Gastrointestin... Author: obr Added: 01/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 24, 2017 Category: Cancer & Oncology Source Type: podcasts

Outcomes of Randomized Phase 2 Study in BRAF-Mutated CRC Patients
Howard S. Hochster, MD of Yale Cancer Center discusses the outcomes of the randomized phase 2 study in BRAF-mutated patients with colorectal cancer at the 2017 Gastrointestinal Cancers Symposium (ASCO... Author: obr Added: 01/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 24, 2017 Category: Cancer & Oncology Source Type: podcasts

Genetic Profiling in Treatment Approach for Patients with CRC
Howard S. Hochster, MD of Yale Cancer Center discusses how genetic profiling has changed the treatment approach for patients with colorectal cancer at the 2017 Gastrointestinal Cancers Symposium (ASCO... Author: obr Added: 01/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 24, 2017 Category: Cancer & Oncology Source Type: podcasts

Using Both TAS-102 and Regorafenib in Metastatic CRC Patients
Howard S. Hochster, MD of Yale Cancer Center discusses how to use both TAS-102 and Regorafenib in patients with metastatic colorectal cancer at the 2017 Gastrointestinal Cancers Symposium (ASCO GI) in... Author: obr Added: 01/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 24, 2017 Category: Cancer & Oncology Source Type: podcasts

Difference between Regorafenib, 5FU, and TAS-102
Howard S. Hochster, MD of Yale Cancer Center discusses the difference between Regorafenib, 5FU, and TAS-102 at the 2017 Gastrointestinal Cancers Symposium (ASCO GI) in San Francisco, CA. Author: obr Added: 01/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 24, 2017 Category: Cancer & Oncology Source Type: podcasts